Recurrence
Showing 9976 - 10000 of >10,000
Prostate Cancer Trial in Chicago (SBRT to whole prostate, IMRT followed by mpMRI guided SBRT boost with SIB to intraprostatic
Active, not recruiting
- Prostate Cancer
- SBRT to whole prostate
- IMRT followed by mpMRI guided SBRT boost with SIB to intraprostatic lesions
-
Chicago, IllinoisRush University Medical Center
Jan 24, 2021
Microwave Ablation or Wedge Resection for Treatment of Lung,
Recruiting
- Lung Non-Small Cell Carcinoma
- +21 more
- Computed Tomography with Contrast
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 10, 2020
Metastatic Pancreatic Cancer Trial in Shanghai (Camrelizumab, Nab paclitaxel, Gemcitabine Injection)
Unknown status
- Metastatic Pancreatic Cancer
- Camrelizumab
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jul 31, 2020
Complications After Ileocolic Resection for Crohn Disease
Completed
- Crohn Disease
- Ileocolic Resection
-
Montpellier, FranceUhmontpellier
Dec 28, 2020
Recurrent Prostate Cancer Trial in Canada, United States (High Intensity Focused Ultrasound)
Unknown status
- Recurrent Prostate Cancer
- High Intensity Focused Ultrasound
-
Los Angeles, California
- +15 more
Apr 9, 2019
Malaria, Vivax, Therapeutics Trial in Manaus (CQ coadministered with PQ, DHA-PQP coadministered with PQ, CQ and PQ starting on
Active, not recruiting
- Malaria, Vivax
- Therapeutics
- CQ coadministered with PQ
- +3 more
-
Manaus, Amazonas, BrazilFundação de Medicina Tropical Dr. Heitor Vieira Dourado
Nov 29, 2021
Metastatic Ovarian Cancer Trial in Bordeaux, Montpellier (Experimental arm)
Completed
- Metastatic Ovarian Cancer
- Experimental arm
-
Bordeaux, France
- +1 more
Oct 16, 2020
Hepatocellular Carcinoma, Malignant Tumor Trial in Beijing (TACE plus autologous Tcm immunotherapy, TACE)
Completed
- Hepatocellular Carcinoma
- Malignant Neoplasm
- TACE plus autologous Tcm immunotherapy
- TACE
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Jun 3, 2020
Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Lenvatinib 1, Camrelizumab 1)
Recruiting
- Hepatocellular Carcinoma
- Portal Vein Thrombosis
- HAIC
- +4 more
-
Beijing, Beijing, ChinaPeking Univerisity Cancer Hospital
Jan 10, 2022
Urinary Incontinence, Stress Trial in Worldwide
Active, not recruiting
- Urinary Incontinence, Stress
-
Antwerp, Belgium
- +27 more
Jan 25, 2022
Glioblastoma Multiforme Trial in Solna (Valganciclovir Tablets, Temozolomide 120 mg, Radiotherapy 60 Gy)
Recruiting
- Glioblastoma Multiforme
- Valganciclovir Tablets
- +3 more
-
Solna, Stockholm, SwedenSE01 Karolinska University Hospital
Sep 3, 2021
Heartburn, Dyspepsia, Reflux Trial in Leuven (de-prescription of PPI via intermittent scheme, de-prescription of PPI via
Not yet recruiting
- Heartburn
- +2 more
- de-prescription of PPI via intermittent scheme
- +2 more
-
Leuven, Vlaams Brabant, BelgiumJan Tack
Nov 16, 2022
Immuno-Deficiency Trial in Caen (Systematic screening of immune deficiency)
Completed
- Immuno-Deficiency
- Systematic screening of immune deficiency
-
Caen, FranceCaen University Hospital
Nov 28, 2022
TCM Syndrome Factors and TSH Changes of Thyroid Hormone
Not yet recruiting
- Differentiated Thyroid Carcinoma
- TCM Syndrome Type
- (no location specified)
Jun 15, 2021
Urinary Incontinence, Stress Trial in Quebec (Contiform pessary)
Terminated
- Urinary Incontinence, Stress
- Contiform pessary
-
Quebec, CanadaHopital St-François d'Assise
Mar 16, 2022
Bradykinin-degradating Enzymes Activities in
Recruiting
- Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
- Assay of Bradykinin-degradating enzymes.
-
Grenoble, FranceChu Grenoble Alpes
Jan 14, 2022
Rectal Cancer Trial in Wuhan (Lap partial ISR, NCRT+Lap partial ISR)
Not yet recruiting
- Rectal Cancer
- Lap partial ISR
- NCRT+Lap partial ISR
-
Wuhan, Hubei, ChinaZhongnan Hospital, Wuhan University
Jul 19, 2020
Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States
Recruiting
- Prostate Adenocarcinoma
- +6 more
- Gonadotrophin Releasing Hormone
- +2 more
-
Gilbert, Arizona
- +86 more
Sep 27, 2022
Osteonecrosis of the Jaw, Bisphosphonate Induced, Osteonecrosis of the Jaw, Bisphosphonate Related Trial in Palma de Mallorca
Recruiting
- Osteonecrosis of the Jaw, Bisphosphonate Induced
- Osteonecrosis of the Jaw, Bisphosphonate Related
- Surgical treatment
-
Palma de Mallorca, Baleares, SpainHospital Universitario Son Espases
Feb 12, 2021
Patent Foramen Ovale Trial in Eugene (PFO Closure)
Enrolling by invitation
- Patent Foramen Ovale
- PFO Closure
-
Eugene, OregonCardiorespiratory and Pulmonary Physiology Lab
Apr 26, 2021
Uterine Cancer, Cervical Cancer Trial in Boston (Proton radiation therapy)
Active, not recruiting
- Uterine Cancer
- Cervical Cancer
- Proton radiation therapy
-
Boston, MassachusettsMassachusetts General Hospital
Jan 12, 2021
Periodic Limb Movement and Genetic Generalized Epilepsy
Completed
- Epilepsy Generalized Idiopathic Not Intractable
- (no location specified)
Jul 13, 2018
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Completed
- Neuroma
- Neurocap®
-
Phoenix, Arizona
- +15 more
Sep 9, 2020
Localized Oesogastric Adenocarcimona, MSI and or dMMR Trial in France (Nivolumab 10 MG/ML, Ipilimumab 200 MG in 40 ML Injection)
Recruiting
- Localized Oesogastric Adenocarcimona
- MSI and or dMMR
- Nivolumab 10 MG/ML
- Ipilimumab 200 MG in 40 ML Injection
-
Besançon, France
- +14 more
Jun 10, 2021